Literature DB >> 29893347

Dedifferentiated adenoid cystic carcinoma ex pleomorphic adenoma of the parotid.

Minakshi Bhardwaj1, Prajwala Gupta1.   

Abstract

Carcinoma ex pleomorphic adenoma (Ca ex PA) is defined as a carcinoma arising from a primary (de novo) or recurrent benign pleomorphic adenoma. The most common histological subtype is adenocarcinoma, not otherwise specified, salivary duct carcinoma, mucoepidermoid carcinoma, and adenoid cystic carcinoma (ACC). Few case reports of de novo dedifferentiation in ACC are there in the literature, mostly involving minor salivary glands. The dedifferentiated adenoid cystic carcinoma arising in a pleomorphic adenoma of the parotid gland has not been reported earlier. The present case highlights this rare histological subtype seen in Ca ex PA and the role of extensive histopathological examination and immunohistochemistry.

Entities:  

Keywords:  Adenoid cystic; carcinoma ex pleomorphic adenoma; dedifferentiation; immunohistochemistry; parotid

Mesh:

Year:  2018        PMID: 29893347     DOI: 10.4103/0973-1482.179522

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN: 1998-4138            Impact factor:   1.805


  3 in total

1.  Adenoid Cystic Carcinoma with Transformation to High Grade Carcinomatous and Sarcomatoid Components: A Rare Case Report with Review of Literature.

Authors:  Anupurva Dutta; Pattatheyil Arun; Indu Arun
Journal:  Head Neck Pathol       Date:  2020-01-02

2.  Comparative Longitudinal Analysis of Malignant Transformation in Pleomorphic Adenoma and Recurrent Pleomorphic Adenoma.

Authors:  Sung Yong Choi; Jaehyuck Choi; Inwoo Hwang; Junhun Cho; Young-Hyeh Ko; Han-Sin Jeong
Journal:  J Clin Med       Date:  2022-03-25       Impact factor: 4.241

Review 3.  Fine needle aspiration of salivary gland carcinomas with high-grade transformation: A multi-institutional study of 22 cases and review of the literature.

Authors:  Masato Nakaguro; William C Faquin; Zubair W Baloch; Richard L Cantley; Margaret L Compton; Kim A Ely; Brittany J Holmes; Rong Hu; Darcy A Kerr; Kathleen T Montone; Michiya Nishino; Liron Pantanowitz; Esther Diana Rossi; Peter M Sadow
Journal:  Cancer Cytopathol       Date:  2020-11-19       Impact factor: 4.264

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.